Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins, Paul Fletcher, William Shanahan
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107417-107417
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Serotonin in Animal Cognition and Behavior
Julien Bacqué-Cazenave, Rahul Bharatiya, Grégory Barrière, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1649-1649
Open Access | Times Cited: 253
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 206
Tobacco and nicotine use
Bernard Le Foll, Megan E. Piper, Christie D. Fowler, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 185
Central 5-HT receptors and their function; present and future
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 160
Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options
Arturo Cesaro, Gianantonio De Michele, Fabio Fimiani, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 51
Therapeutic advances in obesity management: an overview of the therapeutic interventions
Moody Al Roomy, Kainat Hussain, Hawraa M. Behbehani, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 18
A Highly Sensitive Triple Quad LC–MS/MS Method Development and Validation for the Determination of Bexicaserin (LP352) in Human Plasma and Urine Matrices
Raja Reddy Kallem, Meredith Yeager, Rebecca L. Chan, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 1
Enantioselective Synthesis of 1-Dihydrobenzazepines through Rh2(II)-Catalyzed Cycloisomerization of 1,6-Enyne
Chuntao Wang, Zi‐Hao Liao, Rui Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Yang Yang, Bing Zhao, Xuejiao Gao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 52
Advancing targeted protein degradation for metabolic diseases therapy
Qianqian Zhou, Haitao Xiao, Fan Yang, et al.
Pharmacological Research (2022) Vol. 188, pp. 106627-106627
Open Access | Times Cited: 34
Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
Chao Gao, Mikolaj Pielas, Fuyong Jiao, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2532-2532
Open Access | Times Cited: 19
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
Guido Cavaletti, P Marmiroli
Cancers (2020) Vol. 12, Iss. 6, pp. 1370-1370
Open Access | Times Cited: 49
The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results
Cecilie Johannessen Landmark, Heidrun Potschka, Stéphane Auvin, et al.
Epilepsia (2021) Vol. 62, Iss. 4, pp. 857-873
Open Access | Times Cited: 38
Biocatalytic Access to Chiral Benzazepines Using Imine Reductases
Anshul Rajput, Tanaya Manna, Amit Mondal, et al.
ACS Catalysis (2023) Vol. 13, Iss. 9, pp. 6185-6194
Closed Access | Times Cited: 15
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI):II. Drugs in more advanced clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2022) Vol. 63, Iss. 11, pp. 2883-2910
Closed Access | Times Cited: 21
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder
Laura Brandt, Jermaine D. Jones, Suky Martinez, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107859-107859
Open Access | Times Cited: 29
The serotonergic system dysfunction in diabetes mellitus
Yan Cai, Xiaolong Li, Hongli Zhou, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
Green Synthesis and Biological Aspect of Seven‐Membered Azepine Hybrids: A Recent Update”
Annu Bhardwaj, Shivangi Jaiswal, Kanika Verma, et al.
The Chemical Record (2025)
Closed Access
A Sensitive and Selective LC–MS/MS‐ESI Method for the Quantitation of Metabolites M9, M12, and M20 of Bexicaserin in Human Plasma and Urine Matrices
Raja Reddy Kallem, Meredith Yeager, Rebecca L. Chan, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 4
Open Access
Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration
Noelle C. Anastasio, Dennis J. Sholler, Robert G. Fox, et al.
Neuropharmacology (2020) Vol. 168, pp. 108009-108009
Open Access | Times Cited: 25
Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour
Guy A. Higgins, Matthew A. Brown, Jessica St. John, et al.
Neuropharmacology (2020) Vol. 170, pp. 108064-108064
Closed Access | Times Cited: 24
Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?
Meir Bialer, Emilio Perucca
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 113-122
Closed Access | Times Cited: 15
Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy
Hueng‐Chuen Fan, Ming‐Tao Yang, Lung‐Chang Lin, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 31-31
Open Access | Times Cited: 8
Advancements in the management of obesity: a review of current evidence and emerging therapies
Mohammed Abdalla, Emmanuel Ssemmondo, Charlotte Mark‐Wagstaff, et al.
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 3, pp. 257-268
Closed Access | Times Cited: 3
Evaluating bexicaserin for the treatment of Developmental Epileptic Encephalopathies
Giovanni Battista Dell’Isola, Alberto Verrotti, Miriam Sciaccaluga, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1121-1130
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top